Literature DB >> 229713

Mammalian inhibitors of angiotensin converting enzyme (kininase II).

J W Ryan, L C Martin, A Chung, G A Pena.   

Abstract

Urines and sera (human, guinea pig and rat) contain low molecular weight inhibitors of angiotensin converting enzyme (ACE). The urines contain ACE, but the enzyme is scarcely measurable without prior ultrafiltration or dialysis. The activity increases strikingly through three ultrafiltration steps using a membrane with a 10,000 MW retention limit. As implied, the ultrafiltrates contain inhibitory activity and can prevent the hydrolysis of [3H]benzoyl-Gly-His-Leu by ACE from any source, including lung and serum. Human urinary ultrafiltrate contains at least three inhibitors separable on Bio-Gel P-2. The inhibitors are acidic and can be partially purified on Bio-Rex 70 developed with an acetic acid gradient. The smallest of the inhibitors can be purified to apparent homogeneity by partition chromatography (sephadex G-25; butanol, acetic acid, H2O; 4:1:5). The excretion of inhibitory activity varies in response to dietary salt: Activity is low when rats are maintained on a high NaCl diet and is high (3 x's control) on a low NaCl diet. Thus, the activity of ACE may be modulated in vivo by naturally-occurring enzyme inhibitors. Whether some hypertensive patients are deficient in ACE inhibitory activity remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 229713

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  Serum angiotensin converting enzyme in pneumonias.

Authors:  Y Kerttula; T H Weber
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

2.  Conformational changes of blood ACE in chronic uremia.

Authors:  Maxim N Petrov; Valery Y Shilo; Alexandr V Tarasov; David E Schwartz; Joe G N Garcia; Olga A Kost; Sergei M Danilov
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

3.  ACE phenotyping in human heart.

Authors:  Victoria E Tikhomirova; Olga A Kost; Olga V Kryukova; Elena Z Golukhova; Naida I Bulaeva; Aigerim Z Zholbaeva; Leo A Bokeria; Joe G N Garcia; Sergei M Danilov
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

4.  New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human.

Authors:  Miklós Fagyas; Katalin Úri; Ivetta M Siket; Gábor Á Fülöp; Viktória Csató; Andrea Daragó; Judit Boczán; Emese Bányai; István Elek Szentkirályi; Tamás Miklós Maros; Tamás Szerafin; István Édes; Zoltán Papp; Attila Tóth
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

5.  New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases.

Authors:  Miklós Fagyas; Katalin Úri; Ivetta M Siket; Andrea Daragó; Judit Boczán; Emese Bányai; István Édes; Zoltán Papp; Attila Tóth
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

6.  New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.

Authors:  Miklós Fagyas; Katalin Úri; Ivetta M Siket; Andrea Daragó; Judit Boczán; Emese Bányai; István Édes; Zoltán Papp; Attila Tóth
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.